文献速递肝病

原发性胆汁性胆管炎患者沉默性心肌受累的形态、功能与组织特征

Morphological, Functional, and Tissue Characterization of Silent Myocardial Involvement in Patients With Primary Biliary Cholangitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-08-28

这项前瞻性三中心多模态心脏影像研究纳入56例无心脏症状的原发性胆汁性胆管炎(PBC)患者和56例年龄性别匹配对照,用心脏磁共振(CMR)评估亚临床心肌受累。PBC患者出现左室射血分数增高、心肌水肿、细胞外基质指数升高及晚期钆增强(LGE)阳性,室间隔中壁「条纹」为PBC特异性LGE模式。gp210阳性、较低血红蛋白和体重指数是心脏异常的独立预测因素。

要点

  • 无心脏症状的PBC患者已可检出亚临床心肌形态、功能及组织学异常。
  • 室间隔中壁「条纹」LGE模式为PBC特异性表现,有别于其他心肌病。
  • gp210阳性、较低血红蛋白和体重指数是PBC心脏异常的独立预测因素。

核心结论

  • PBC患者在无心脏症状阶段已存在具有特定CMR模式的临床沉默性心脏受累。
  • 该发现支持对PBC早期心肌受累进行优化筛查并可能及时治疗。

研究设计与样本

  • 前瞻性、三中心、多模态心脏影像研究(EARLY-MYO-PBC,试验注册号NCT03545672)。
  • 共纳入112名受试者,包括56例PBC患者和56例年龄、性别匹配的对照,均接受心脏磁共振(CMR)检查。
  • 所有参与者无心脏不适或既往心脏病史,心电图检查正常。

主要发现

  • PBC患者左室射血分数呈高动力状态,中位数75%,对照为69%(P = .029)。
  • T2-short tau inversion recovery显示亚临床心肌水肿,PBC患者21%,对照2%(P = .001)。
  • 细胞外基质指数升高,PBC患者30%,对照26%(P < .001)。
  • 晚期钆增强(LGE)阳性提示心肌活性受损,见于36%的PBC患者。
  • 室间隔中壁「条纹」被识别为PBC特异性LGE模式,不同于其他已知心肌病。

关键数值与推荐

  • 多因素分析显示gp210阳性(OR = 9.909,P = .010)为PBC心脏异常的独立预测因素。
  • 较低血红蛋白(OR = 0.919,P = .004)为PBC心脏异常的独立预测因素。
  • 体重指数(OR = 0.638,P = .005)为PBC心脏异常的独立预测因素。

临床怎么用

  • 对无心脏症状的PBC患者可考虑使用CMR筛查亚临床心肌受累。
  • 关注gp210阳性、较低血红蛋白及较低体重指数的PBC患者,其心脏异常风险更高。
  • 识别室间隔中壁「条纹」LGE模式有助于提示PBC相关心肌受累。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Cirrhotic cardiomyopathy is a major complication and cause of morbidity in end-stage primary biliary cholangitis (PBC). However, it is unclear whether there is clinically silent myocardial involvement at the early stage of PBC before cirrhosis and cardiac manifestations. This prospective, three-center, multi-modality cardiac imaging study on the early identification of myocardial impairment in PBC (EARLY-MYO-PBC) was designed to identify silent myocardial impairment in PBC patients without cardiac manifestations. METHODS: A total of 112 subjects (56 with PBC and 56 age- and sex-matched controls) undergoing cardiovascular magnetic resonance (CMR) were enrolled. Demographic, serologic, and cardiac imaging data were prospectively collected. All participants had no cardiac discomfort or previous heart disease and had normal electrocardiographic findings. RESULTS: Subclinical myocardial involvement, as evidenced by cardiac morphologic, functional, and tissue characterization changes on CMR, including hyperdynamic left ventricular (LV) ejection fraction (median, 75% in PBC patients vs 69% in controls, P = .029), subclinical myocardial edema by T2-short tau inversion recovery (21% vs 2% in controls, P = .001), elevated extracellular matrix indices (30% vs 26% in controls, P < .001), and impaired myocardial viability by positive late gadolinium enhancement (LGE) (36%), was detected in PBC patients. Importantly, a mid-wall "stripe" at the LV septum was identified as a PBC-specific LGE pattern that differs from other known cardiomyopathies. In multivariate analysis, gp210 positivity (odds ratio [OR] = 9.909, P = .010), lower hemoglobin (OR = 0.919, P = .004), and body mass index (OR = 0.638, P = .005) were independent predictors of cardiac abnormalities in PBC. CONCLUSIONS: This study demonstrates clinically silent cardiac impairment with specific CMR patterns in PBC, allowing optimal screening for early myocardial impairment and potentially timely therapies. (Trial registration no.: NCT03545672).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Jiang P, Feng Z, Sheng L, et al. Morphological, Functional, and Tissue Characterization of Silent Myocardial Involvement in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2021. PMID: 34461299. doi:10.1016/j.cgh.2021.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。